Season 1, Episode 2
Innovation Unleashed: Exploring the Intersection of Science and Creativity – An Unconventional Growth Strategy
Sabine and Jennifer explore the captivating world where biotech science and creativity unite. Discover their secrets to success and get inspired by the boundless possibilities that emerge when these two forces intertwine.
Join Seuss+ CEO and Co-Founder Sabine Hutchison as she delves into the remarkable growth strategy and remarkable journey of Agenus Bio, a standout player in the competitive Biotech industry, a unique organization that chooses to be purposefully different. Jennifer reveals the story behind their success, discussing the importance of in-house capabilities, a patient-focused approach, and strategic collaborations that have set them apart in this heavily regulated field.
Sabine and Jennifer explore the captivating world where science and creativity unite. Discover their secrets to success and get inspired by the boundless possibilities that emerge when these two forces intertwine. Tune in for a riveting discussion that illuminates the path to a future shaped by the transformative synergy of science and creativity in biotechnology.
Jennifer Buell – Bio
Dr. Jennifer Buell is the Chairman, Executive Council at Agenus and the President and CEO at MiNK Therapeutics, with over 27 years of biopharmaceutical experience. She has led teams through discovery to clinical development and commercialization. Previously, she served as President and COO at Agenus, overseeing research, clinical development, manufacturing, and more, transforming the company into a global biotech with strategic partnerships. Before that, she held leadership positions at Bristol-Myers Squibb and Harvard Clinical Research Institute (Baim), contributing to development strategies for clinical programs. Dr. Buell earned her Ph.D. in Cellular, Biochemical, and Molecular Biochemistry, along with an M.S. in Biostatistics from Tufts University.
Join the discussion and listen to the full episode here.
Get This Episode
Listen on your preferred platform right here:
Related Episodes
S2 E4 – AI in Biotech: Hype, Reality, and the Future of Drug Development
Season 2, Episode 4 AI in Biotech: Hype, Reality, and the Future of Drug DevelopmentIn the fourth episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the very insightful AI thought leader Christina Busmalis. Their conversation, titled...
S2 E3 – Transforming Clinical Trials: How Digital Endpoints Are Leading the Way
Season 2, Episode 3 Transforming Clinical Trials: How Digital Endpoints Are Leading the WayIn the third episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by Victoria Bangieva from the Digital Medicine Society (DiMe) and our very own...
Key takeaways
- Science and creativity are not opposites, and treating them as one strategy is unconventional on purpose.
- Growth in biotech does not only come from the science, it comes from how the organization is built around it.
- [ogs_entity format="name"] hosts this conversation with Agenus Bio.
Frequently asked questions
One that treats creativity as an operational asset rather than a nice-to-have, and builds the company around the science instead of behind it.
Sabine Hutchison in conversation with Jen from Agenus Bio.
In the decisions nobody scripts: how teams solve problems, how they respond when the data surprises them, and how the organization gets built around the work.
Stay Connected to Get The Latest Podcast Alerts
CUT THE CHAT - LIFE SCIENCE INSIDER
Listen Now!
An informative podcast series designed quite literally to cut the unnecessary talk and get straight to the point and heart of many life science and biotech conversations that need to happen for our industry to evolve, innovate and get smarter—faster.
